The global chlamydia diagnosis and treatment market is anticipated to grow at a considerable CAGR of 6.0% during the forecast period (2024-2031). The rising pervasiveness of chlamydia trachomatis disease is one of the prime factors affecting and driving the market. According to U.S. Department of Health & Human Services, chlamydia is considered to be one of the common sexually transmitted infections in the US that is affecting around 2.86 million infections every year.
Get Free Sample link @ https://www.omrglobal.com/request-sample/chlamydia-diagnosis-treatment-market
The key players operating in the global chlamydia diagnosis and treatment market had been adopting strategy to gain major market share. For instance, in March 2021, Binx health had received approval from the US Food and Drug Administration (FDA) for Clinical Laboratory Improvement Amendments (CLIA) waiver. CLIA is considered to be the molecular point of care testing platform for diagnosis of chlamydia (CT) and gonorrhea (NG) which, will give result in around 30 minutes of time.
Full report of Chlamydia Diagnosis and Treatment Market available @ https://www.omrglobal.com/industry-reports/chlamydia-diagnosis-treatment-market
Market Coverage
• Segment Covered-
o By Diagnosis Methods
o By Treatment Approach
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Abbott, Binx health inc., Diazyme Laboratories, Inc., Hologic, Inc., and F. Hoffmann-La Roche Ltd.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Chlamydia Diagnosis and Treatment Market – Segmentation
By Diagnosis Methods
• Chlamydia Culture
• Urine Culture
• Enzyme Immunoassays
• Nucleic Acid Amplification Test
By Treatment Approach
• Oral Antibiotics
• Injectable
By End-User
• Hospitals
• Diagnostic Centers
• Research Institutions
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/chlamydia-diagnosis-treatment-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
